Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study

[1] Utsumi T(2015)External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study Jpn J Clin Oncol 45 1091-1095

[2] Oka R(2020)Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology Int J Clin Oncol 25 732-740

[3] Endo T(2020)The impact of complications after initial prosate biopsy on repeat protocol biopsy acceptance rate. Results from the Ptostate Cancer Research International: Active Surveillance JAPAN study Int J Clin Oncol 26 956-970

[4] Ito K(2019)Global incidence of prostate cancer in developing and developed countries with changing age structures PLoS ONE 14 1-9

[5] Furuta A(2014)Occurrence of infection following prostate biopsy procedures in Japan Japanese Research Group for Urinary Tract Infection (JRGU)—a multi-center retrospective study J Infect Chemother 20 232-237

[6] Kido A(2019)Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli Int J Urol 26 655-660

[7] Tohi Y(2020)Infectious complications of prostate biopsy: winning battles but not war World J Urol 38 2743-2753

[8] Kato T(2019)Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis World J Surg Oncol 17 1-11

[9] Matsumoto R(2017)Prevention of infectious complications after prostate biopsy procedure Int J Urol 24 486-492

[10] Teoh JYC(2019)Emergency attendances and hospitalisations for complications after transrectal ultrasound-guided prostate biopsies: a five-year retrospective multicentre study Hong Kong Med J 25 349-355

[1] Utsumi T(2015)External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study Jpn J Clin Oncol 45 1091-1095

[2] Oka R(2020)Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology Int J Clin Oncol 25 732-740

[3] Endo T(2020)The impact of complications after initial prosate biopsy on repeat protocol biopsy acceptance rate. Results from the Ptostate Cancer Research International: Active Surveillance JAPAN study Int J Clin Oncol 26 956-970

[4] Ito K(2019)Global incidence of prostate cancer in developing and developed countries with changing age structures PLoS ONE 14 1-9

[5] Furuta A(2014)Occurrence of infection following prostate biopsy procedures in Japan Japanese Research Group for Urinary Tract Infection (JRGU)—a multi-center retrospective study J Infect Chemother 20 232-237

[6] Kido A(2019)Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli Int J Urol 26 655-660

[7] Tohi Y(2020)Infectious complications of prostate biopsy: winning battles but not war World J Urol 38 2743-2753

[8] Kato T(2019)Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis World J Surg Oncol 17 1-11

[9] Matsumoto R(2017)Prevention of infectious complications after prostate biopsy procedure Int J Urol 24 486-492

[10] Teoh JYC(2019)Emergency attendances and hospitalisations for complications after transrectal ultrasound-guided prostate biopsies: a five-year retrospective multicentre study Hong Kong Med J 25 349-355